Overview
ZBH market data
Price History
ZBH price chart · 1M
- O
- 99.98
- H
- 101.27
- L
- 99.55
- C
- 99.97
- Vol
- 65,651.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $99.98
- Previous Close
- $101.40
- Day High
- $101.27
- Day Low
- $99.55
- 52 Week High
- $102.11
- 52 Week Low
- $78.94
- 7 Day Return
- +0.91%
- 30 Day Return
- +4.41%
- 90 Day Return
- +21.72%
- 1 Year Return
- +25.18%
- Daily Notional Volume
- $6.6M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 23.12 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.55 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $79.12 – $108.29 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $18.6B · P/B 1.40 · P/S 2.19.
Company News
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100Benzinga · Aug 10, 2026, 11:58 AM
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106Benzinga · Aug 7, 2026, 1:29 PM
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110Benzinga · Aug 6, 2026, 6:04 PM
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93Benzinga · Aug 6, 2026, 4:47 PM
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110Benzinga · Aug 6, 2026, 2:25 PM
8-K filing — ZIMMER BIOMET HOLDINGS, INC. (ZBH)SEC EDGAR · Aug 5, 2026, 8:11 PM
Zimmer Biomet Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.Benzinga · Aug 5, 2026, 11:35 AM
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B EstBenzinga · Aug 5, 2026, 10:32 AM
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B EstimateBenzinga · Aug 5, 2026, 10:31 AM
Shares of medical device-related companies are trading higher following comments from HCA Healthcare on a conference call that business declines from uninsured patients didn't occur as expected in Q2, which is bullish for the medical device and equipment outlook following the end of ACA subsidies.Benzinga · Jul 24, 2026, 5:51 PM